All articles by Alvaro Arjona

Alvaro Arjona is Editor-in-Chief at GlobalData Media, with extensive experience in leading editorial teams covering Pharma & Healthcare. Former Editorial Director of Thomson Reuters Drug News, Alvaro started his career making significant contributions to the field of Immunology at Yale School of Medicine. He has also led scientific communications at UCB Pharma and developed data-driven clinical intelligence products at Informa Pharma Intelligence.

Alvaro Arjona

Features

Magazine: Are metaverse applications becoming a reality in medical training?

In this issue: metaverse applications for medical training, microneedle technologies, why digital pills aren’t taking off, a tsunami of clinical trial data with connected devices, and more.

Features

Magazine: How noninvasive NASH tests can move the needle

In this issue, we take a look at noninvasive tests in NASH, the future of ALS devices, monkeypox testing kits, and more.

Comment

Securing the future foundation for a digital NHS

Matt Barnes, Maintel’s Head of Health & Housing, shares his vision for an IT network architecture fit for the NHS’ digital journey.

Features

Two long years of Covid-19 pandemic: lasting questions for pharma and healthcare

Editorial: Medical Device Network provides an outlook on what to expect from emerging pharma and medical paradigms as the world transitions to an endemic Covid-19 state.

Features

Deconstructing the decentralised clinical trial continuum: who is doing what?

Editorial: A remote revolution is transforming how clinical research is devised – but ambiguity in decentralisation approaches can curb adoption.